Press release
Arthralgia Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis
DelveInsight's "Arthralgia Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Arthralgia, historical and forecasted epidemiology as well as the Arthralgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Arthralgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Arthralgia Market Forecast [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Arthralgia Market Report:
*
The Arthralgia market size is estimated to grow with a significant CAGR during the study period (2019-2032)
*
Arthralgia affected women more than it did men, according to DelveInsight's data. For example, in Japan in 2021, there were about 34,000 cases of Arthralgia in males and about 39,000 in females.
*
Key Arthralgia Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
*
Key Arthralgia Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab and others
*
The Arthralgia epidemiology based on gender analyzed that the prevalence of moderate cases is the highest, followed by severe and mild cases
*
The Arthralgia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Arthralgia pipeline products will significantly revolutionize the Arthralgia market dynamics.
Arthralgia Overview
Arthralgia is a medical term used to describe pain or discomfort in one or more joints. Joints are the connections between bones, and arthralgia can affect various parts of the body, such as the knees, elbows, wrists, or shoulders. The pain associated with arthralgia can be caused by inflammation, injury, infection, or other underlying conditions affecting the joints.
Get a Free sample for the Arthralgia Market Report:
https://www.delveinsight.com/report-store/arthralgia-market [https://www.delveinsight.com/report-store/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Arthralgia Epidemiology Segmentation:
The Arthralgia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
*
Total Prevalence of Arthralgia
*
Prevalent Cases of Arthralgia by severity
*
Gender-specific Prevalence of Arthralgia
*
Diagnosed Cases of Episodic and Chronic Arthralgia
Download the report to understand which factors are driving Arthralgia epidemiology trends @ Arthralgia Epidemiology Forecast [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Arthralgia market or expected to get launched during the study period. The analysis covers Arthralgia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Arthralgia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Arthralgia Therapies and Key Companies
*
ILUMYA: Sun Pharma
*
Deucravacitinib: Bristol-Myers Squibb
*
Bimekizumab: UCB Biopharma
*
Izokibep: Affibody AB
*
SUNPG18_07: Sun Pharmaceutical Industries Limited
*
VTX958: Ventyx Biosciences, Inc
*
ATI-450: Aclaris Therapeutics, Inc.
*
Risankizumab: AbbVie
*
Upadacitinib: AbbVie
*
AIN457: Novartis
*
Ustekinumab: Janssen Research & Development, LLC
*
Sonelokimab: MoonLake Immunotherapeutics AG
Discover more about therapies set to grab major Arthralgia market share @ Arthralgia Treatment Market [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Market Strengths
*
Increased prevalence, growth in awareness, and lifestyle changes have necessitated changes in the diagnosis and treatment of PsA in the recent decade
*
Various screening tools, including self-administered questionnaires, have been developed to help dermatologists, rheumatologist, and general physicians to identify patients who might suffer from PsA
Arthralgia Market Unmet Needs
*
Lack of biomarkers
*
Challenges in current treatment options
*
Challenges in current guidelines
*
Poor disease understanding
*
Challenges in managing comorbidities
Scope of the Arthralgia Market Report
*
Study Period: 2019-2032
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Arthralgia Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
*
Key Arthralgia Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab, and others
*
Arthralgia Therapeutic Assessment: Arthralgia current marketed and Arthralgia emerging therapies
*
Arthralgia Market Dynamics: Arthralgia market drivers and Arthralgia market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Arthralgia Unmet Needs, KOL's views, Analyst's views, Arthralgia Market Access and Reimbursement
To know more about Arthralgia companies working in the treatment market, visit @ Arthralgia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Arthralgia Market Report Introduction
2. Executive Summary for Arthralgia
3. SWOT analysis of Arthralgia
4. Arthralgia Patient Share (%) Overview at a Glance
5. Arthralgia Market Overview at a Glance
6. Arthralgia Disease Background and Overview
7. Arthralgia Epidemiology and Patient Population
8. Country-Specific Patient Population of Arthralgia
9. Arthralgia Current Treatment and Medical Practices
10. Arthralgia Unmet Needs
11. Arthralgia Emerging Therapies
12. Arthralgia Market Outlook
13. Country-Wise Arthralgia Market Analysis (2019-2032)
14. Arthralgia Market Access and Reimbursement of Therapies
15. Arthralgia Market Drivers
16. Arthralgia Market Barriers
17. Arthralgia Appendix
18. Arthralgia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=arthralgia-market-to-reach-new-heights-in-growth-by-2032-delveinsight-predicts-sun-pharma-bristolmyers-squibb-ucb-biopharma-affibody-ventyx-biosciences-aclaris-therapeutics-abbvie-novartis]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Arthralgia Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis here
News-ID: 3969999 • Views: …
More Releases from ABNewswire
Is Couples Therapy Right? Signs It's Time to See a Counsellor in Birmingham
Relationships can be both fulfilling and challenging. No matter how strong a couple may seem on the outside, it's natural to face hurdles along the way. Miscommunication, stress, life changes, or unresolved issues can create distance between partners. While every couple goes through ups and downs, knowing when to seek professional support can make all the difference. If you've ever found yourself searching for "couples therapy near me" or wondering…
Rialto-Based Get it from Bo Pioneers Collaborative E-Commerce Model Supporting M …
Get it from Bo revolutionizes online retail through strategic manufacturer partnerships that deliver quality products at reasonable prices. The California-based platform, established in 2024, creates sustainable business relationships while expanding inventory daily to serve diverse consumer needs.
Get it from Bo is establishing new standards in the e-commerce industry through its innovative collaborative approach that prioritizes sustainable partnerships with manufacturers and brands while delivering exceptional value to consumers. The Rialto, California-based…
Daily Vibe Launches Comprehensive Fitness Products Store for Diverse Consumer Ma …
New fitness retailer Daily Vibe enters the market with targeted product selections designed to support active lifestyles across multiple demographics. The startup focuses on serving fitness enthusiasts, health-conscious consumers, and older adults seeking quality fitness products.
Founded by Ja'von L. Watson and Joyleena S. Watson, AGAIT International is a fast-growing Atlanta-based tech company dedicated to solving social and economic challenges through creative business and digital solutions. The company develops and manages…
Prolift Handling Brings Advanced pewag Lifting Technology to Ireland
Prolift Handling launches pewag levo Balancer and levo Compensator in Ireland - two advanced lifting solutions that improve safety and precision in heavy lifting operations through remote-controlled positioning and automatic load balancing.
Dublin, Ireland - Sep 30, 2025 - Prolift Handling, Ireland's exclusive pewag partner, today launched two advanced lifting solutions designed to tackle the industry's most challenging safety and precision requirements: the pewag levo Balancer and pewag levo Compensator.
The pewag…
More Releases for Arthralgia
Arthralgia Market Growth, Applications, Innovations and Business Outlook by 2034
Introduction
Arthralgia, or joint pain, is a common clinical symptom associated with a wide range of conditions, including osteoarthritis, rheumatoid arthritis, lupus, infections, and injury-related disorders. While not a disease itself, arthralgia significantly impacts patient quality of life and is one of the leading reasons for clinical visits globally.
Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/71333
Historically managed with analgesics, NSAIDs, and corticosteroids, the treatment landscape is evolving with the expansion…
Arthralgia Treatment Market 2025 | Biologics, Gene Therapy & Digital Health Inno …
The Global Arthralgia Treatment Market is witnessing strong growth driven by factors such as the rising prevalence of joint pain and arthritis, an aging global population, and ongoing advancements in pain management therapies, including NSAIDs, corticosteroids, biologics, and personalized medicine approaches. Emerging opportunities in the arthralgia treatment market are rapidly evolving with the development of novel biologics and gene therapies that offer long-term and targeted symptom relief, significantly improving patient…
Global Arthralgia Treatment Market Overview, Trends & Competitive Strategies | 2 …
Global Arthralgia Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Arthralgia Treatment Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with the knowledge needed to make strategic decisions and maintain a competitive advantage. Utilizing a blend of qualitative and…
Arthralgia Management Market Size, Share, Price, Trends, Growth, Analysis, Repor …
The global arthralgia management market share value was USD 6.55 billion in 2023, driven by the rising prevalence of autoimmune disorders, overuse injuries, and infectious diseases. The market size is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032 to achieve a value of USD 14.34 billion by 2032.
Arthralgia Management: Introduction
Arthralgia, or joint pain, is a common complaint among individuals of varying ages and can…
Arthralgia Treatment Market
Market Overview
The global Arthralgia Treatment Market is projected to experience a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030.
Understanding Arthralgia
Arthralgia, commonly known as joint pain, can affect various joints in the body, leading to discomfort and reduced mobility. It is associated with diverse conditions, including arthritis, bursitis, tendinitis, overuse injuries, gout, and other inflammatory disorders. Arthralgias may also result from the side effects of…
Arthralgia Drugs Market Size, Demand, and Future Outlook: Global Industry Trends …
This Arthralgia Drugs market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics,…
